After watching the part CEO bio conference presentation I happened to notice that I did not see in any of the slides, examples of the 40% plaque reduction in the mouse studies done years previously.  Why are they ignoring those past studies,  Is it because there is no point and mute as they know already from a "wink wink" from the current ASSURE tiral  that rvx 208 actually works in humans and there is no point in using animal studies in presentations now.   What about in the latest blog on hdl therapies the wording that RVX 208 is " highly active" in promoting RCT.  Then there is the ALT that many say is actually showing that the drug is doing what it suppose to do and flushing plague throught the liver and that is actually what needs to be doing.


All very intersting in my opinion